A Phase III, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study of theSafety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in PediatricSubjects

Project: Research project

Project Details

Description

A Phase III, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study of the Safety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in Pediatric Subjects
StatusActive
Effective start/end date3/1/212/28/26

Funding

  • OCUMENSION THERAPEUTICS LTD

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.